B. G. Masresha, M. G. Dixon, and J. L. Kriss, Progress toward measles elimination-African Region, MMWR Morb Mortal Wkly Rep, vol.66, issue.17, pp.436-443, 2017.
DOI : 10.15585/mmwr.mm6617a2

URL : https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6617a2.pdf

, World Health Organization. Measles vaccines: WHO position paper, Wkly Epidemiol Rec, vol.84, issue.35, pp.349-360, 2009.

, World Health Organization. Data, statistics and graphics, 4.5: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) [estimates for 1980 to, 2016.

, Data, statistics and graphics: Retrospective Measles Data on Supplementary Immunization Activities, 2000.

, World Health Organization. WHO vaccine-preventable diseases: monitoring system. Global summary-Incidence time series for Madagascar, 2007.

A. R. Mclean, After the honeymoon in measles control, Lancet, vol.345, issue.8945, p.272, 1995.

S. Verguet, M. Johri, and S. K. Morris, Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy, Vaccine, vol.33, issue.10, pp.1291-1296, 2015.

F. T. Cutts and M. Hanson, Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low-and middle-income countries, Trop Med Int Health, vol.21, issue.9, pp.1086-1098, 2016.

F. T. Cutts, H. S. Izurieta, and D. A. Rhoda, Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys, PLoS Med, vol.10, issue.5, p.1001404, 2013.

J. Lessler, C. J. Metcalf, and R. F. Grais, Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis, PLoS Med, vol.8, issue.10, p.1001110, 2011.

, Centers for Disease Control and Prevention. Measles outbreaks and progress toward measles preelimination-African region, MMWR Morb Mortal Wkly Rep, vol.60, issue.12, pp.374-378, 2009.

A. Minetti, M. Kagoli, and A. Katsulukuta, Lessons and challenges for measles control from unexpected large outbreak, Malawi. Emerg Infect Dis, vol.19, issue.2, pp.202-209, 2013.

S. Kidd, B. Ouedraogo, and C. Kambire, Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness, Vaccine, vol.30, issue.33, pp.5000-5008, 2012.

F. J. Luquero, H. Pham-orsetti, and D. A. Cummings, A longlasting measles epidemic in Maroua, Cameroon 2008-2009: mass vaccination as response to the epidemic, J Infect Dis, vol.204, issue.1, pp.243-251, 2011.

N. Hens, Z. Shkedy, and M. Aerts, Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: a Modern Statistical Perspective, 2012.

C. J. Metcalf, J. Farrar, and F. T. Cutts, Use of serological surveys to generate key insights into the changing global landscape of infectious disease, Lancet, vol.388, pp.728-730, 2016.

F. Trentini, P. Poletti, and S. Merler, Measles immunity gaps and the progress towards elimination: a multi-country

, Am J Epidemiol, vol.187, issue.10, pp.2219-2226, 2018.

, Measles Outbreak Risk in Madagascar 2225

, by Institut Pasteur user on 21 November 2018 modelling analysis, vol.17, pp.1089-1097, 2017.

E. Massad, M. N. Burattini, . De-azevedo, and R. S. Neto, A modelbased design of a vaccination strategy against rubella in a nonimmunized community of Sao Paulo State, Brazil. Epidemiol Infect, vol.112, issue.3, pp.579-594, 1994.

J. M. Prada, C. Metcalf, and S. Takahashi, Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world-Can elimination be maintained?, Vaccine, vol.35, issue.11, pp.1488-1493, 2017.

H. Heesterbeek, R. M. Anderson, and V. Andreasen, Modeling infectious disease dynamics in the complex landscape of global health, Science, vol.347, issue.6227, p.4339, 2015.

S. Takahashi, C. J. Metcalf, and M. J. Ferrari, Reduced vaccination and the risk of measles and other childhood infections post-Ebola, Science, vol.347, issue.6227, pp.1240-1242, 2015.

B. J. Cohen, R. P. Parry, and D. Doblas, Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay, J Virol Methods, vol.131, issue.2, pp.209-212, 2006.

J. C. Ruckdeschel, K. D. Graziano, and M. R. Mardiney, Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola), Cell Immunol, vol.17, issue.1, pp.11-18, 1975.

, World Population Prospects: The 2015 Revision, 2018.

C. Loader, Local Regression and Likelihood, 1999.

E. Simons, M. Ferrari, and J. Fricks, Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data, Lancet, vol.379, issue.9832, pp.2173-2178, 2012.

N. Boulianne, D. Serres, G. Ratnam, and S. , Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination, Vaccine, vol.13, issue.16, pp.1611-1616, 1995.

P. E. Fine, Herd immunity: history, theory, practice, Epidemiol Rev, vol.15, issue.2, pp.265-302, 1993.

R. M. Anderson and R. M. May, Infectious Diseases of Humans: Dynamics and Control, 1991.

J. Mossong, N. Hens, and M. Jit, Social contacts and mixing patterns relevant to the spread of infectious diseases, PLoS Med, vol.5, issue.3, p.74, 2008.

P. Klepac and H. Caswell, The stage-structured epidemic: linking disease and demography with a multi-state matrix approach model, Theor Ecol, vol.4, issue.3, pp.301-319, 2011.

B. T. Grenfell and R. M. Anderson, The estimation of age-related rates of infection from case notifications and serological data, J Hyg (Lond), vol.95, issue.2, pp.419-436, 1985.

R. M. Anderson and R. M. May, Age-related-changes in the rate of disease transmission: implications for the design of vaccination programs, J Hyg (Lond), vol.94, issue.3, pp.365-436, 1985.

W. J. Moss and D. E. Griffin, Global measles elimination, Nat Rev Microbiol, vol.4, issue.12, pp.900-908, 2006.

N. J. Gay, L. M. Hesketh, and P. Morgan-capner, Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy, Epidemiol Infect, vol.115, issue.1, pp.139-156, 1995.

A. J. Vyse, N. J. Gay, and L. M. Hesketh, Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century, Epidemiol Infect, vol.134, issue.6, pp.1303-1312, 2006.

, Guidance on Conducting Serosurveys in Support of Measles and Rubella Elimination in the WHO European Region, 2013.

N. Gay, M. Ramsay, and B. Cohen, The epidemiology of measles in England and Wales since the 1994 vaccination campaign, Commun Dis Rep CDR Rev, vol.7, issue.2, pp.17-21, 1997.

W. Nigatu, D. Samuel, and B. Cohen, Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys, Vaccine, vol.26, issue.37, pp.4769-4774, 2008.

W. O. Kermack and A. G. Mckendrick, A contribution to the mathematical theory of epidemics, Proc R Soc Lond, vol.115, issue.772, pp.700-721, 1927.

G. The-vaccine-alliance, Measles and measles-rubella vaccine support, 2014.

P. Duclos and B. J. Ward, Measles vaccines: a review of adverse events, Drug Saf, vol.19, issue.6, pp.435-454, 1998.

A. J. Tatem, A. J. Garcia, and R. W. Snow, Millennium development health metrics: where do Africa's children and women of childbearing age live?, Popul Health Metr, vol.11, p.11, 2013.

. Worldpop, Madagascar 100m Population, 2018.

, Am J Epidemiol, vol.187, issue.10, pp.2219-2226, 2018.